University of Tsukuba in Tsukuba City, Ibaraki Prefecture, announced that it will begin clinical trials on a next-generation treatment for a brain disease. Glioblastoma, a type of intractable cancer, is a brain.
disease with a 5-year survival rate of around 10%. Even with surgery and other treatments, the. risk of recurrence is high, and no treatment has yet been established. By using the uniquely developed device, the company says it will be able to shorten treatment time and provide treatment to more patients.